fbpx
March 3, 2023

Risk for Stent Infection Low but May Be Underreported Risk for Stent Infection Low but May Be Underreported

Infections of coronary stents appear to be uncommon, but it is not clear if they are often missed, underreported, or truly rare, according to a new […]
March 3, 2023

Real-World Data Show Regorafenib on Par With TAS-102 in Metastatic CRC Real-World Data Show Regorafenib on Par With TAS-102 in Metastatic CRC

In what is believed to be the largest real-world comparison, overall survival was similar in patients with refractory metastatic colorectal cancer (CRC) who received regorafenib (Stivarga) […]
March 3, 2023

Focused Ultrasound Ablation Reduces Dyskinesia in Parkinson’s Focused Ultrasound Ablation Reduces Dyskinesia in Parkinson’s

An incisionless surgical procedure that uses focused ultrasound ablation (FUSA) to target the globus pallidus internus of patients with Parkinson’s disease (PD) significantly reduced tremors and improved […]
March 3, 2023

HER2-Low Breast Cancer Is NOT a Separate Clinical Entity: Study HER2-Low Breast Cancer Is NOT a Separate Clinical Entity: Study

Much attention has been focused recently on the idea that breast cancer with a low expression of HER2 can be treated with HER-2 targeted agents. Not […]
March 3, 2023

First Prospective Study of TKI Ponatinib Shows Benefit in Ph+ALL First Prospective Study of TKI Ponatinib Shows Benefit in Ph+ALL

Ponatinib, a potent third-generation tyrosine kinase inhibitor (TKI), showed superior efficacy and comparable safety vs the first-generation TKI imatinib in patients with newly diagnosed Philadelphia chromosome-positive […]
March 3, 2023

Triplet Not Always Better Than Doublet in mCSPC Triplet Not Always Better Than Doublet in mCSPC

For men with metastatic castration-sensitive prostate cancer (mCSPC), a combination of three drugs may not always be better than two drugs, say researchers. Contemporary androgen deprivation […]
March 3, 2023

New Documentary Highlights Human Toll of High Insulin Cost New Documentary Highlights Human Toll of High Insulin Cost

A new documentary premiering at the 2023 South by Southwest (SXSW) Festival illustrates the human consequences of insulin’s high cost in the United States. Its creators […]
March 3, 2023

FDA Official Who Oversaw Aducanumab Approval Retiring FDA Official Who Oversaw Aducanumab Approval Retiring

A US Food and Drug Administration (FDA) official who oversaw the approval of the controversial Alzheimer’s therapy aducanumab (Aduhelm) is retiring from the agency to ‘explore […]
March 3, 2023

Stop Giving Thiazides to Prevent Recurrent Kidney Stones? Stop Giving Thiazides to Prevent Recurrent Kidney Stones?

Hydrochlorothiazide, which for decades has been a standard treatment to prevent the recurrence of calcium-containing kidney stones, did not lower the rate of stone recurrence in the […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792793794795796797798799800801802803804
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0